2021
DOI: 10.1007/s00535-021-01808-w
|View full text |Cite
|
Sign up to set email alerts
|

Reducing adenoma miss rate of colonoscopy assisted by artificial intelligence: a multicenter randomized controlled trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
88
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 61 publications
(89 citation statements)
references
References 29 publications
0
88
1
Order By: Relevance
“…We believe that such validation methods would be more preferable in a developmental phase to decide the appropriate direction of research and also to reveal the strengths and weaknesses of CADe. In fact, a prospective multi-center randomized trial evaluating AMR as the primary outcome in a tandem study design, in which the CADe-assisted group achieved better AMR than the non-assisted group, was warranted from the desirable results of this retrospective trial [23].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We believe that such validation methods would be more preferable in a developmental phase to decide the appropriate direction of research and also to reveal the strengths and weaknesses of CADe. In fact, a prospective multi-center randomized trial evaluating AMR as the primary outcome in a tandem study design, in which the CADe-assisted group achieved better AMR than the non-assisted group, was warranted from the desirable results of this retrospective trial [23].…”
Section: Discussionmentioning
confidence: 99%
“…Meanwhile, the advantage of assistance from a DL-based CADe system over non-assisted human perception has already been demonstrated in several randomized controlled trials (RCTs), including our study evaluating ADR or the adenoma miss rate (AMR) as the primary outcome. The result was confirmed in a series of meta-analyses, some of which analyzed the outcomes of RCTs [22][23][24][25]. However, RCT demands a significant amount of effort and time; retesting each updated DL-based algorithm using RCT may be suboptimal as a reference to set the direction of algorithmic developments.…”
Section: Introductionmentioning
confidence: 87%
“…In the last couple of years, automated polyp detection has been studied in several prospective trials looking primarily at AMR and ADR. Three relatively new tandem randomized controlled trials (RCTs) published in 2020 and 2021 demonstrated that AMR was significantly decreased in the CADe group compared to the standard colonoscopy group [13][14][15] (e.g., 13,8% vs. 36,7% in a Japanese multicenter trial and 20.12% vs. 31.25% in a US multicenter trial). Additionally, an increasing number of prospective trials studying the effect of AI on ADR have been published, mainly from China [16][17][18][19][20][21][22][23] but also from Italy conducted in a multi-center fashion.…”
Section: Cade and Computer-aided Quality Improvementmentioning
confidence: 99%
“…Recently published tandem randomized controlled trial in Japan showed that two LST-NG-type advanced adenomas (13.3% of all the advanced adenomas) were missed with standard colonoscopy but immediately picked up in the following AI-assisted colonoscopy. 7 It would be interesting to see how more accumulated data in randomized controlled trials and meta-analyses will change our mind towards the use of AI in terms of detection of subtle, elusive, but advanced lesions. Actually, another meta-analysis indicated that the use of AI increased the mean number of advanced adenomas per colonoscopy.…”
mentioning
confidence: 99%